Nature Communications (Nov 2022)
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer
- Jeffrey S. Damrauer,
- Wolfgang Beckabir,
- Jeff Klomp,
- Mi Zhou,
- Elizabeth R. Plimack,
- Matthew D. Galsky,
- Petros Grivas,
- Noah M. Hahn,
- Peter H. O’Donnell,
- Gopa Iyer,
- David I. Quinn,
- Benjamin G. Vincent,
- Diane Zipursky Quale,
- Sara E. Wobker,
- Katherine A. Hoadley,
- William Y. Kim,
- Matthew I. Milowsky
Affiliations
- Jeffrey S. Damrauer
- Lineberger Comprehensive Cancer Center, University of North Carolina
- Wolfgang Beckabir
- Lineberger Comprehensive Cancer Center, University of North Carolina
- Jeff Klomp
- Lineberger Comprehensive Cancer Center, University of North Carolina
- Mi Zhou
- Lineberger Comprehensive Cancer Center, University of North Carolina
- Elizabeth R. Plimack
- Department of Hematology and Oncology, Fox Chase Cancer Center, Temple Health
- Matthew D. Galsky
- Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Petros Grivas
- Department of Medicine, Division of Medical Oncology, University of Washington
- Noah M. Hahn
- Johns Hopkins University School of Medicine
- Peter H. O’Donnell
- Section of Hematology/Oncology, Department of Medicine, University of Chicago
- Gopa Iyer
- Memorial Sloan Kettering Cancer Center
- David I. Quinn
- University of Southern California Norris Comprehensive Cancer Center
- Benjamin G. Vincent
- Lineberger Comprehensive Cancer Center, University of North Carolina
- Diane Zipursky Quale
- Bladder Cancer Advocacy Network
- Sara E. Wobker
- Lineberger Comprehensive Cancer Center, University of North Carolina
- Katherine A. Hoadley
- Lineberger Comprehensive Cancer Center, University of North Carolina
- William Y. Kim
- Lineberger Comprehensive Cancer Center, University of North Carolina
- Matthew I. Milowsky
- Lineberger Comprehensive Cancer Center, University of North Carolina
- DOI
- https://doi.org/10.1038/s41467-022-33980-9
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 15
Abstract
The Bladder Cancer Advocacy Network established the UC-GENOME study in order to create a biobank and data repository for metastatic urothelial carcinoma. Here, the authors present the first characterization and analysis of DNA and RNA sequencing data from the 218 patients included in the UC-GENOME.
